Search This Blog

Wednesday, April 3, 2024

Addex, Perceptive Launch Neurosterix with $63 M to Accelerate Neurological Therapeutics

 Addex receives CHF5M and 20% share of Neurosterix

 Perceptive Advisors leads $63M investment into Neurosterix 

Addex contributes portfolio of preclinical neuroscience assets and allosteric modulator small molecule discovery technology platform to Neurosterix

https://www.globenewswire.com/news-release/2024/04/03/2856583/0/en/Addex-and-Perceptive-Launch-Neurosterix-with-63-Million-to-Accelerate-Development-of-Allosteric-Modulator-Therapeutics-for-Neurological-Disorders.html

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)